Synopsys (SNPS) Tops Q3 EPS by 24c; offers guidance
Get Alerts SNPS Hot Sheet
Financial Fact:
Research and development: 221.95M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Synopsys (NASDAQ: SNPS) reported Q3 EPS of $3.91, $0.24 better than the analyst estimate of $3.67. Revenue for the quarter came in at $2.48 billion versus the consensus estimate of $2.44 billion.
GUIDANCE:
Synopsys sees Q4 2026 EPS of $4.10-$4.16, versus the consensus of $3.99. Synopsys sees Q4 2026 revenue of $2.53-2.58 billion, versus the consensus of $2.552 billion.
Synopsys sees FY2026 EPS of $15.04-$15.10, versus the consensus of $14.77. Synopsys sees FY2026 revenue of $9.69-9.74 billion, versus the consensus of $9.677 billion.
For earnings history and earnings-related data on Synopsys (SNPS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
- Urban Outfitters (URBN) Misses Q2 EPS by 1c
- NVIDIA (NVDA) Tops Q2 EPS by 14c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share